Kimberly Sullivan

Kimberly Sullivan possesses extensive experience in regulatory affairs, quality, and compliance within the pharmaceutical industry, currently serving as President and CEO of Development Insights since 2010. Prior to this role, Kimberly served as an independent consultant specializing in quality, compliance, and regulatory affairs. Previous positions include Director of Compliance, Quality, and Regulatory Affairs at Speciality European Pharma and Director of Quality at Praecis Pharmaceuticals. Other notable roles include Principal Manager of Regulatory Affairs/Quality Assurance at Inotek Pharmaceuticals and Manager of Quality Systems/Regulatory Affairs at Collagenesis, Inc. Kimberly’s career began in quality assurance and technical services at Toxikon Corporation and spans back to technical roles in Earth and Marine Sciences at Arthur D. Little.